Carregant...
Retained products of conception in hysteroscopy in a patient with breast cancer on tamoxifen
Tamoxifen is a selective oestrogen receptor modulator widely used in breast cancer treatment, with good survival rates. Its partial agonist action on other tissues such as the uterus, however, promotes the development of endometrial hyperplasia and cancer. It appears that tamoxifen does not alter th...
Guardat en:
| Publicat a: | BMJ Case Rep |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6721742/ https://ncbi.nlm.nih.gov/pubmed/31473640 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2019-230635 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|